Ruconest

Home / Ruconest

Ruconest – Hereditary Angioedema leads to the swelling of extreme body parts. Ruconest is the first FDA-approved recombinant C1 esterase inhibitor (C1-INH), plasma-free drug for the treatment of HAE.

Optimed Infusion is a private infusion suite in Columbus Ohio

Salix and Pharming Announce FDA Approval of RUCONEST® for the Treatment of Acute Angioedema Attacks in Patients with Hereditary Angioedema (HAE)

Ruconest for Treatment of Hereditary Angioedema (HAE)

US Hereditary Angioedema Association – HAEA

 

CONTACT


All the fields are required